Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Champions Oncology, Inc. - Common Stock (NQ: CSBR )

11.07 +0.01 (+0.09%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Champions Oncology, Inc. - Common Stock

< Previous 1 2 Next >
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Recap: Champions Oncology Q2 Earnings
Via Benzinga
Earnings Scheduled For December 11, 2024
Via Benzinga
A Peek at Champions Oncology's Future Earnings
Via Benzinga
A Preview Of Champions Oncology's Earnings
Via Benzinga
Champions Oncology: Q3 Earnings Insights
Via Benzinga
Earnings Outlook For Champions Oncology
Via Benzinga
Recap: Champions Oncology Q2 Earnings
Via Benzinga
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Kroger, Adobe And 3 Stocks To Watch Heading Into Thursday
Via Benzinga
CSBR Stock Earnings: Champions Oncology Beats EPS, Beats Revenue for Q4 2024
CSBR stock results show that Champions Oncology beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Earnings Outlook For Champions Oncology
Via Benzinga
Champions Oncology Earnings Perspective: Return On Capital Employed
Via Benzinga
Champions Oncology's Earnings: A Preview
Via Benzinga
Champions Oncology's Earnings: A Preview
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Earnings Scheduled For March 12, 2024
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter. 
Via Benzinga
Champions Oncology's Return On Capital Employed Insights
Via Benzinga
Insiders Buying Solid Biosciences And 2 Other Stocks
Although U.S. stocks closed mixed on Friday, there were a few notable insider trades. 
Via Benzinga
Insiders Buying Tilly's And 2 Other Stocks
Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades. 
Via Benzinga
Why Is RiskOn International (ROI) Stock Up 28% Today?
RiskOn International stock is rising higher on Wednesday as investors react to insider buying of ROI shares by Milton C. Ault III. 
Via InvestorPlace
CSBR Stock Earnings: Champions Oncology Beats EPS, Misses Revenue for Q2 2024
CSBR stock results show that Champions Oncology beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Earnings Scheduled For December 12, 2023
Companies Reporting Before The Bell • CSP (NASDAQ:CSPI) is likely to report earnings for its fourth quarter. 
Via Benzinga
Johnson Controls, Oracle And 3 Stocks To Watch Heading Into Tuesday
With U.S. stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Investor Optimism Improves Further Ahead Of Inflation Data; Dow Gains For Third Straight Day
The CNN Money Fear and Greed index showed further improvement in overall market sentiment, while the index remained in the "Greed" zone on Monday. U.S. stocks closed higher on Monday, with the Dow... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
$5M Bet On Pyxis Oncology? Check Out These 4 Penny Stocks Insiders Are Buying
The Dow Jones closed higher by more than 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Analyzing Champions Oncology's Short Interest
Champions Oncology's (NASDAQ:CSBR) short percent of float has risen 6.9% since its last report. The company recently reported that it has 64 thousand shares sold short, which is 0.93% of all regular... 
Via Benzinga
Earnings Scheduled For March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million. 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.